Association Between Quantitative and Qualitative Imaging Biomarkers and Geographic Atrophy Growth Rate.

PURPOSE: Investigate associations between geographic atrophy (GA) growth rate and multimodal imaging biomarkers and patient demographics in patients with advanced non-neovascular age-related macular degeneration (nnAMD).

DESIGN: Prospective cohort study.

METHODS: 121 eyes of 66 patients with advanced nnAMD with GA enrolled in the University of Colorado AMD Registry from August 2014 to June 2021, with follow-up through June 2023. Multimodal images were reviewed by two graders for imaging biomarkers at enrollment. GA growth rate and square-root transformed (SQRT) GA growth rate were measured between enrollment and final visit. Associations between the outcome SQRT GA growth rate and imaging biomarkers, baseline GA lesions characteristics, and patient demographics were evaluated.

RESULTS: Average GA growth rate was 1.430mm2 /year and SQRT GA growth rate was 0.268mm/year over a mean of 3.7years. SQRT GA growth rate was positively associated with patient age (p=0.010) and female sex (0.035), and negatively associated with body mass index (0.041). After adjustment for these demographic factors, SQRT GA growth rate was positively associated with presence of non-exudative subretinal fluid (p<0.001), non-exudative subretinal hyperreflective material (p=0.037), and incomplete retinal pigment epithelium and outer retina atrophy (p=0.022), and negatively associated with subfoveal choroidal thickness (p=0.031) and presence of retinal pseudocysts (p=0.030). Larger baseline GA size at enrollment was associated with faster GA growth rate (p=0.002) but not SQRT GA growth rate.

CONCLUSIONS: Select patient demographic factors and basic clinically-relevant imaging biomarkers were associated with GA growth rate. These biomarkers may guide patient selection when considering treating GA patients with novel therapeutics.